|
1
|
Chen L and Li J, Li Q, Yan H, Zhou B, Gao
Y and Li J: Non-coding RNAs: The new insight on hypertrophic scar.
J Cell Biochem. 118:1965–1968. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lee HJ and Jang YJ: Recent understandings
of biology, prophylaxis and treatment strategies for hypertrophic
scars and keloids. Int J Mol Sci. 19(711)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang J, Yu L, Xu Y, Liu Y, Li Z, Xue X,
Wan S and Wang H: Long noncoding RNA upregulated in hypothermia
treated cardiomyocytes protects against myocardial infarction
through improving mitochondrial function. Int J Cardiol.
266:213–217. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Li X, Wu Z, Fu X and Han W: lncRNAs:
Insights into their function and mechanics in underlying disorders.
Mutat Res Rev Mutat Res. 762:1–21. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shan G, Tang T, Xia Y and Qian HJ: Long
non-coding RNA NEAT1 promotes bladder progression through
regulating miR-410 mediated HMGB1. Biomed Pharmacother.
121(109248)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang X, Guan MX, Jiang QH, Li S, Zhang
HY, Wu ZG, Cong HL and Qi XH: NEAT1 knockdown suppresses
endothelial cell proliferation and induces apoptosis by regulating
miR-638/AKT/mTOR signaling in atherosclerosis. Oncol Rep.
44:115–125. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
lncRNA NEAT1 facilitates cell
proliferation, invasion and migration by regulating CBX7 and RTCB
in breast cancer (retraction). Onco Targets Ther.
13(7807)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang J, Zhao B, Chen X, Wang Z, Xu H and
Huang B: Silence of long noncoding RNA NEAT1 inhibits malignant
biological behaviors and chemotherapy resistance in gastric cancer.
Pathol Oncol Res. 24:109–113. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gu G, Hu C, Hui K, Chen T, Zhang H and
Jiang X: NEAT 1 knockdown enhances the sensitivity of human
non-small-cell lung cancer cells to anlotinib. Aging (Albany NY).
13:13941–13953. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li C, Liu YF, Huang C, Chen YX, Xu CY and
Chen Y: Long noncoding RNA NEAT1 sponges miR-129 to modulate renal
fibrosis by regulation of collagen type I. Am J Physiol Renal
Physiol. 319:F93–F105. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen X, Xie D, Zhao Q and You ZH:
MicroRNAs and complex diseases: From experimental results to
computational models. Brief Bioinform. 20:515–539. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wu X, Li J, Yang X, Bai X, Shi J, Gao J,
Li Y, Han S, Zhang Y, Han F, et al: miR-155 inhibits the formation
of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT
pathway. J Mol Histol. 49:377–387. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang X, Zhang Y, Jiang BH, Zhang Q, Zhou
RP, Zhang L and Wang C: Study on the role of Hsa-miR-31-5p in
hypertrophic scar formation and the mechanism. Exp Cell Res.
361:201–209. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bi S, Chai L, Yuan X, Cao C and Li S:
MicroRNA-98 inhibits the cell proliferation of human hypertrophic
scar fibroblasts via targeting Col1A1. Biol Res.
50(22)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li J, Chen L, Cao C, Yan H, Zhou B, Gao Y,
Li Q and Li J: The long non-coding RNA LncRNA8975-1 is upregulated
in hypertrophic scar fibroblasts and controls collagen expression.
Cell Physiol Biochem. 40:326–334. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kirkpatrick LD, Shupp JW, Smith RD,
Alkhalil A, Moffatt LT and Carney BC: Galectin-1 production is
elevated in hypertrophic scar. Wound Repair Regen. 29:117–128.
2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tian S, Zheng Y, Xiao S, Luo P, Sun R, Liu
J and Xia Z: Ivermectin inhibits cell proliferation and the
expression levels of type I collagen, α-SMA and CCN2 in
hypertrophic scar fibroblasts. Mol Med Rep. 24(488)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo
B: Long noncoding RNA (lncRNA)-mediated competing endogenous RNA
networks provide novel potential biomarkers and therapeutic targets
for colorectal cancer. Int J Mol Sci. 20(5758)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Peng Q, Li L and Bi X: Long noncoding RNA
small nuclear RNA host gene 7 knockdown protects mouse cardiac
fibroblasts against myocardial infarction by regulating
miR-455-3p/platelet-activating factor receptor axis. J Cardiovasc
Pharmacol. 77:796–804. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tu L, Huang Q, Fu S and Liu D: Aberrantly
expressed long noncoding RNAs in hypertrophic scar fibroblasts
in vitro: A microarray study. Int J Mol Med. 41:1917–1930.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wu Q, Chen J, Tan Z, Wang D, Zhou J, Li D
and Cen Y: Long non-coding RNA (lncRNA) nuclear enriched abundant
transcript 1 (NEAT1) regulates fibroblast growth factor receptor
substrate 2 (FRS2) by targeting microRNA (miR)-29-3p in
hypertrophic scar fibroblasts. Bioengineered. 12:5210–5219.
2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang J, Dodd C, Shankowsky HA, Scott PG
and Tredget EE: Wound Healing Research Group. Deep dermal
fibroblasts contribute to hypertrophic scarring. Lab Invest.
88:1278–1290. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bai X, He T, Liu J, Wang Y, Fan L, Tao K,
Shi J, Tang C, Su L and Hu D: Loureirin B inhibits fibroblast
proliferation and extracellular matrix deposition in hypertrophic
scar via TGF-β/Smad pathway. Exp Dermatol. 24:355–360.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu F, Chen WW, Li Y, Zhang JQ and Zheng
QB: MiR-6836-3p promotes proliferation of hypertrophic scar
fibroblasts by targeting CTGF. Eur Rev Med Pharmacol Sci.
22:4069–4074. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Deng J, Shi Y, Gao Z, Zhang W, Wu X, Cao W
and Liu W: Inhibition of pathological phenotype of hypertrophic
scar fibroblasts via coculture with adipose-derived stem cells.
Tissue Eng Part A. 24:382–393. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hamed S, Ullmann Y, Egozi D, Daod E,
Hellou E, Ashkar M, Gilhar A and Teot L: Fibronectin potentiates
topical erythropoietin-induced wound repair in diabetic mice. J
Invest Dermatol. 131:1365–1374. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang X, Song Z, Hu B, Chen Z, Chen F and
Cao C: MicroRNA-642a-5p inhibits colon cancer cell migration and
invasion by targeting collagen type I α1. Oncol Rep. 45:933–944.
2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang Q, Peng Z, Xiao S, Geng S, Yuan J and
Li Z: RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin
fibroblasts. Exp Dermatol. 16:611–617. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang E, Gao B, Yang L, Wu X and Wang Z:
Notoginsenoside Ft1 promotes fibroblast proliferation via
PI3K/Akt/mTOR signaling pathway and benefits wound healing in
genetically diabetic mice. J Pharmacol Exp Ther. 356:324–332.
2016.PubMed/NCBI View Article : Google Scholar
|
